Endobiliary radiofrequency ablation of malignant hilar obstruction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004849

Enrollment

Registered

2020-03-23

Start date

2020-12-10

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : Percutaneous RF ablation is performed to ablate intraductal tumor in pateints with malignant hilar obstruction. A Endobiliary RF ablation device (ELRA electrode (A3

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - radiologically or histologically proven malignant hilar obstruction - patient who signed consent for biliary stent placement - age 19-90

Exclusion criteria

Exclusion criteria: - possible curative resection - inability to biliary access due to previous surgery - life expectancy 2.0, platelet<5k - pregnancy, inability to obtain written consent

Design outcomes

Primary

Measure	Time frame
stent patency	—

Secondary

Measure	Time frame
survival	—

Countries

Korea, Republic of

Contacts

Public ContactChang Jin Yoon

Seoul National University Bundang Hospital

yooncj1@gmail.com+82-31-787-7619

Outcome results